FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

517011000001100: Celance 250microgram tablets (Eli Lilly & Co Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16775901000001116 Celance 250microgram tablets (Eli Lilly & Co Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41154001000001113 Celance 250microgram tablets (Eli Lilly and Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Is a Product containing precisely pergolide 250 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Is a Pergolide 250microgram tablets true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Is a Pergolide 250microgram tablets false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has active ingredient Pergolide mesilate false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has active ingredient Pergolide false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Is a Celance true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pergolide true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has specific active ingredient Pergolide mesilate true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) Has basis of strength substance Pergolide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Celance 250microgram tablets (Eli Lilly & Co Ltd) 100 tablet 10 x 10 tablets Is pack of False Celance 250microgram tablets (Eli Lilly & Co Ltd) Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 6 tablet Is pack of False Celance 250microgram tablets (Eli Lilly & Co Ltd) Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Is pack of False Celance 250microgram tablets (Eli Lilly & Co Ltd) Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has AMP True Celance 250microgram tablets (Eli Lilly & Co Ltd) Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 6 tablet Has AMP True Celance 250microgram tablets (Eli Lilly & Co Ltd) Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 100 tablet 10 x 10 tablets Has AMP True Celance 250microgram tablets (Eli Lilly & Co Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start